» Articles » PMID: 16569690

Comparative Genomic Hybridisation in Malignant Deciduoid Mesothelioma

Overview
Journal J Clin Pathol
Specialty Pathology
Date 2006 Mar 30
PMID 16569690
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Malignant deciduoid mesothelioma is a rare variant of epithelioid mesothelioma. This tumour generally has poor prognosis, and can be asbestos related.

Aim: To identify peculiar genetic changes responsible for critical phases in pathogenesis of malignant deciduoid mesothelioma and their prognostic relevance.

Methods: Comparative genomic hybridisation was carried out in six cases of malignant pleural deciduoid mesothelioma, four sporadic and two familial. All cases were found to be asbestos related. Four patients died during follow-up and the mean survival was 29.5 (SD 14.2, range 12-43) months.

Results: Genetic abnormalities were found in all the tumour tissues, the most frequent being chromosomal gains at 1p, 12q, 17, 8q, 19 and 20 and losses at 13q, 6q and 9p. Survival was found to be longer in those patients who presented a smaller number of losses (< or =2) in the tumorous chromosomes.

Conclusions: Although numerous genetic changes are presented by deciduoid mesotheliomas, certain chromosomal regions are preferentially affected. The clinical outcome for this mesothelioma subtype is predicted by the number of losses.

Citing Articles

Malignant Pleural Mesothelioma: Genetic and Microenviromental Heterogeneity as an Unexpected Reading Frame and Therapeutic Challenge.

Abbott D, Bortolotto C, Benvenuti S, Lancia A, Filippi A, Stella G Cancers (Basel). 2020; 12(5).

PMID: 32392897 PMC: 7281319. DOI: 10.3390/cancers12051186.


Deciduoid type malignant pleural mesothelioma: a case report.

Okita R, Nojima Y, Saisho S, Shimizu K, Shirai R, Kanomata N AME Case Rep. 2018; 2:43.

PMID: 30506035 PMC: 6232047. DOI: 10.21037/acr.2018.09.02.


Metastasis of a pleural mesothelioma to a hyperplastic stomach polyp: an increase of vimentin expression is seen during a gain in deciduoid morphology.

Soltermann A, Pache J, Vogt P Rare Tumors. 2012; 3(4):e52.

PMID: 22355507 PMC: 3282457. DOI: 10.4081/rt.2011.e52.

References
1.
De Rienzo A, Jhanwar S, Testa J . Loss of heterozygosity analysis of 13q and 14q in human malignant mesothelioma. Genes Chromosomes Cancer. 2000; 28(3):337-41. View

2.
Cher M, MacGrogan D, Bookstein R, Brown J, Jenkins R, Jensen R . Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer. Genes Chromosomes Cancer. 1994; 11(3):153-62. DOI: 10.1002/gcc.2870110304. View

3.
Chen C, Brabham W, Stultz B, Frierson Jr H, Barrett J, Sawyers C . Defining a common region of deletion at 13q21 in human cancers. Genes Chromosomes Cancer. 2001; 31(4):333-44. DOI: 10.1002/gcc.1152. View

4.
Serio G, Scattone A, Pennella A, Giardina C, Musti M, Valente T . Malignant deciduoid mesothelioma of the pleura: report of two cases with long survival. Histopathology. 2002; 40(4):348-52. DOI: 10.1046/j.1365-2559.2002.01373.x. View

5.
Shanks J, Harris M, Banerjee S, Eyden B, Joglekar V, Nicol A . Mesotheliomas with deciduoid morphology: a morphologic spectrum and a variant not confined to young females. Am J Surg Pathol. 2000; 24(2):285-94. DOI: 10.1097/00000478-200002000-00015. View